Second Asian Consensus on Irritable Bowel Syndrome

Kok-Ann GWEE; Sutep GONLACHANVIT; Uday-C GHOSHAL; Andrew-S-B CHUA; Hiroto MIWA; Justin WU; Young-Tae BAK; Oh-Young LEE; Ching-Liang LU; Hyojin PARK; Minhu CHEN; Ari-F SYAM; Philip ABRAHAM; Jose SOLLANO; Chi-Sen CHANG; Hidekazu SUZUKI; Xiucai FANG; Shin FUKUDO; Myung-Gyu CHOI; Xiaohua HOU; Michio HONGO.
Journal of Neurogastroenterology and Motility ; : 343-362, 2019.
Artículo en Inglés | WPRIM | ID: wpr-765958

Documentos relacionados

  1. [Management of functional bowel disorders].
  2. Dysbiosis in Irritable Bowel Syndrome.
  3. Irritable bowel syndrome - less irritable, or better treatments?
  4. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
  5. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
  6. Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia.
  7. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
  8. Integrated Virtual Care for Irritable Bowel Syndrome: A Qualitative Study.
  9. Updates in functional dyspepsia and bloating.
  10. [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].